Business Context and Reporting Period
Company: United Bankshares, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 26, 2024
Reporting Period: This filing reports a specific corporate governance event occurring on August 26, 2024, rather than a financial reporting period.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
The primary material change reported is a corporate governance action:
- Board Expansion: The Board of Directors increased its size to fifteen (15) members.
- New Appointment: Dr. Sara DuMond was appointed as an independent director to fill the vacancy created by the board expansion.
- Effective Date: The appointment is effective October 21, 2024.
- Committee Assignments: Dr. DuMond has not yet been appointed to any Board committees.
Guidance, Outlook, and Risks
Compensation: Dr. DuMond will receive compensation in accordance with the company's standard arrangements for non-employee directors, as detailed in the 2024 proxy statement filed on April 2, 2024.
Related Party Transactions: The filing states there are no transactions or arrangements between Dr. DuMond and any other person required to be disclosed under Item 404(a) of Regulation S-K.
Outlook and Risks: The filing does not provide updated financial guidance, management commentary on future performance, or new risk factors.
Investor Verification Checklist
- Verify the effective date of Dr. DuMond's board service (October 21, 2024).
- Review the 2024 Proxy Statement (Schedule 14A) filed on April 2, 2024, for details on non-employee director compensation.
- Monitor future filings for Dr. DuMond's committee assignments.
- Confirm the total Board size is now 15 members.